Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 75 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8784881

    Liposomal curcumin for treatment of diseases

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  2. US 8785492

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  3. US 8785421

    Use of vitamin D in dairy mastitis treatment

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  4. US 8785373

    Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  5. US 8785414

    Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  6. US 8778889

    Antimicrobial decapeptide oral hygiene treatment

    The United States of America as represented by the Secretary of the Army · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  7. US 8778997

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  8. US 8779156

    Analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  9. US 8779090

    Methods and compositions for the treatment of heart failure and other disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  10. US 8778897

    Method of treatment using α-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  11. US 8778608

    CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  12. US 8772238

    Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  13. US 8765731

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  14. US 8759325

    Compositions and methods of treatment for inflammatory diseases

    The Regents of the University of Oklahoma · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

  15. US 8759340

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

  16. US 8759318

    Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

    University College Cardiff Consultants Limited · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

  17. US 8748408

    Methods of treatment of mitochondrial disorders

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  18. US 8747845

    Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  19. US 8747843

    Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor

    The Board of Regents of the University of Texas System · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  20. US 8740872

    Magnetically-targeted treatment for cardiac disorders

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  21. US 8742141

    Inhibition and treatment of prostate cancer metastasis

    Northwestern University · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  22. US 8735414

    Indole derivatives and methods for antiviral treatment

    PTC THERAPEUTICS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted

  23. US 8734799

    Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer

    The Regents of the University of California · Granted May 27, 2014 · Expires May 22, 2034

    granted

  24. US 8735360

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.